IWF vs PRWCX: 25% overlap
iShares Russell 1000 Growth ETF and T. Rowe Price Capital Appreciation share 25.0% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 4 months apart — PRWCX as of 2026-03-31, the rest through 2026-07-23. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.8. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
IWF and PRWCX hold 25 of the same securities. The ten contributing most to the overlap figure:
| Holding | in IWF | in PRWCX | Δ |
|---|---|---|---|
| MSFT | 4.4% | 4.2% | 0.2% |
| AAPL | 7.8% | 3.6% | 4.2% |
| META | 3.4% | 3.7% | 0.3% |
| NVDA | 15.1% | 3.0% | 12.1% |
| GOOGL | 5.7% | 2.3% | 3.5% |
| AVGO | 5.7% | 1.8% | 3.9% |
| AMD | 2.7% | 1.4% | 1.4% |
| MA | 1.3% | 0.9% | 0.4% |
| LLY | 2.9% | 0.8% | 2.1% |
| NFLX | 0.9% | 0.7% | 0.2% |
Where IWF and PRWCX differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | IWF | PRWCX | Δ |
|---|---|---|---|
| Information Technology | 55.0% | 17.8% | +37.2pp |
| Unclassified | 0.0% | 20.3% | −20.3pp |
| Treasuries | 0.0% | 18.2% | −18.2pp |
| Communication Services | 15.7% | 6.7% | +9.0pp |
| Industrials | 8.5% | 0.9% | +7.6pp |
| Utilities | 0.3% | 7.1% | −6.8pp |
| Health Care | 5.6% | 12.2% | −6.6pp |
| Cash & Other | 0.0% | 5.0% | −5.0pp |
Δ is IWF minus PRWCX, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
40.6% of IWF by weight, held in no part of PRWCX.
60.0% of PRWCX by weight, held in no part of IWF.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| IWF | PRWCX | |
|---|---|---|
| Top 10 holdings | 56.1% | 46.0% |
| Positions held | 370 | 151 |
| Cost per $10,000 held, per year | $19 | $72 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do IWF and PRWCX overlap?
IWF and PRWCX overlap 25.0% by portfolio weight — moderate overlap. They share 25 holdings. The figure comes from current issuer holdings files (IWF as of 2026-07-23, PRWCX as of 2026-03-31).
How is the overlap between IWF and PRWCX calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If IWF holds a stock at 6% and PRWCX holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both IWF and PRWCX?
That depends on your goals — we state facts, not advice. At 25.0% overlap, each fund still contributes meaningfully distinct exposure.
What does IWF own that PRWCX doesn't?
IWF holds 370 positions and PRWCX holds 151; 344 of IWF's positions don't appear in PRWCX at all, and they are 40.6% of IWF by weight.
You probably hold more than two funds
This page compares IWF and PRWCX. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch IWF vs PRWCX
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, IWF as of 2026-07-23, PRWCX as of 2026-03-31. Weights are fractions of each fund. Diagnostics, not advice.